Repurposing FDA-approved drugs targeting FZD10 in nasopharyngeal carcinoma: insights from molecular dynamics simulations and experimental validation
Chawalit Ngernsombat(Thammasat University), Tavan Janvilisri(Mahidol University)
Cited by 5
Related Papers
Andrographolide Inhibits Cholangiocarcinoma Cell Migration by Down-Regulation of Claudin-1 via the p-38 Signaling Pathway
|Frontiers in Pharmacology|2019|32